• Mashup Score: 0
    Development of Imaging Endpoints - 11/18 - 1 year(s) ago

    Exploring potential pathways for development of imaging endpoints for clinical trials in AL and ATTR amyloidosis.

    Source: The Amyloidosis Forum
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of Amyloidosis_ARC
      Amyloidosis_ARC

      The #AmyloidosisForum is taking a break for lunch, but we'll see everyone at 1:05pm ET for the second half of our sessions, examining pathways to qualifying imaging for #amyloidosis clinical trials, moderated by Preston Dunnmon. Watch online here: https://t.co/Ck8RIbmUzm https://t.co/KRRTNAscGq

  • Mashup Score: 0
    Development of Imaging Endpoints - 11/18 - 1 year(s) ago

    Exploring potential pathways for development of imaging endpoints for clinical trials in AL and ATTR amyloidosis.

    Source: The Amyloidosis Forum
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of Amyloidosis_ARC
      Amyloidosis_ARC

      Join us today for the #AmyloidosisForum, exploring the different imaging modalities currently being used in AL/ATTR #amyloidosis. 30 + speakers, 20+ institutions, 10+ sessions, 1 goal. It’s not too late, register to watch online: https://t.co/Ck8RIbmUzm https://t.co/OovMfEtOlc

  • Mashup Score: 0
    Imaging As Surrogate Endpoints - 11/18/22 - 1 year(s) ago

    Exploring potential pathways for development of imaging endpoints for clinical trials in AL and ATTR amyloidosis.

    Source: The Amyloidosis Forum
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of Amyloidosis_ARC
      Amyloidosis_ARC

      The #AmyloidosisForum is tomorrow, hosted by @US_FDA! Excited to have @i_lousada, @radigun1, @DorbalaSharmila, Preston Dunnmon and 30+ speakers discussing Pathways for Development of Imaging Endpoints for Clinical Trials in AL and ATTR #amyloidosis: https://t.co/Ck8RIbEvqU https://t.co/Da7gh80cUc

  • Mashup Score: 2
    Imaging As Surrogate Endpoints - 11/18/22 - 2 year(s) ago

    Exploring how imaging is being used in AL/ATTR amyloidosis and identifying challenges to use as endpoints in interventional clinical trials

    Source: The Amyloidosis Forum
    Categories: Cardiologists, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of MasriAhmadMD
      MasriAhmadMD

      Register for in-person or virtual attendance for a packed day of imaging and its endpoints in #amyloidosis at the @US_FDA this Friday 11/18 https://t.co/yTfTkk1TPz #CardioTwitter #MedTwitter #echofirst #CVNuc #WhyCMR https://t.co/6zUgbW9E8W

  • Mashup Score: 1
    Imaging As Surrogate Endpoints - 11/18/22 - 2 year(s) ago

    Exploring how imaging is being used in AL/ATTR amyloidosis and identifying challenges to use as endpoints in interventional clinical trials

    Source: The Amyloidosis Forum
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of Amyloidosis_ARC
      Amyloidosis_ARC

      Patients are at the heart of everything we do. That's why we're glad to have our Founder & CEO, @i_lousada, share her story with imaging & #amyloidosis at the #AmyloidosisForum on Friday, as well as what we've learned from our recent patient poll. https://t.co/zdFhgHIeRP https://t.co/LGe9uf4C36

  • Mashup Score: 2
    Imaging As Surrogate Endpoints - 11/18/22 - 2 year(s) ago

    Exploring how imaging is being used in AL/ATTR amyloidosis and identifying challenges to use as endpoints in interventional clinical trials

    Source: The Amyloidosis Forum
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of Amyloidosis_ARC
      Amyloidosis_ARC

      Very excited to have @MasriAhmadMD presenting a case study detailing the role of imaging in the approval of Mavacamten in oHCM at this Friday's #AmyloidosisForum. Sure to prompt great discussion regarding the use of imaging in #amyloidosis studies: https://t.co/zdFhgHIeRP https://t.co/2E5MdgClUD

  • Mashup Score: 0
    Imaging As Surrogate Endpoints - 11/18/22 - 2 year(s) ago

    Exploring how imaging is being used in AL/ATTR amyloidosis and identifying challenges to use as endpoints in interventional clinical trials

    Source: The Amyloidosis Forum
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of Amyloidosis_ARC
      Amyloidosis_ARC

      Just a few days left until the #AmyloidosisForum! Preston Dunnmon will start our afternoon focus on the Pathway to Surrogacy by laying the groundwork for what is needed for imaging to qualify as a surrogate endpoint in #amyloidosis studies. See you Friday: https://t.co/zdFhgHIeRP https://t.co/2LbEtWNiSG

Load More